Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2003
05/06/2003CA2018676C Novel heteropolymeric protein production methods
05/02/2003EP1306437A2 Delta opioid receptor genes
05/02/2003EP1306431A1 Tumor antigen
05/02/2003EP1306430A1 Process for producing recombined protein
05/02/2003EP1306095A2 Methods and compositions for targeting the vasculature of solid tumors
05/02/2003EP1305636A2 Screening method
05/02/2003EP1305437A2 Expression of biologically active polypeptides in duckweed
05/02/2003EP1305434A2 A human disintegrin protein
05/02/2003EP1305425A2 Drug metabolizing enzymes
05/02/2003EP1305419A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
05/02/2003EP1305418A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
05/02/2003EP1305417A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
05/02/2003EP1305416A2 Identification of a novel glutamine transporter
05/02/2003EP1305415A1 Protein inhibitor of apoptosis proteins
05/02/2003EP1305412A2 Anthozoa derived chromo/fluoroproteins and methods for using the same
05/02/2003EP1305411A1 Method of producing functional protein domains
05/02/2003EP1305409A2 Renal regulatory elements and methods of use thereof
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305399A1 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid
05/02/2003EP1305343A2 Peptides presented by cells
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305341A1 Dog melanin-concentrating hormone receptor
05/02/2003EP1305340A2 Sequences for integrin alpha-8
05/02/2003EP1305334A1 Urocortin proteins and uses thereof
05/02/2003EP1305039A2 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
05/02/2003EP1154703B1 Method for preparing protein hydrolysates
05/02/2003EP1036167B1 Nuclear targeting by means of streptococcal protein h
05/02/2003EP0929578B1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
05/02/2003EP0802983B1 Expression of urokinase plasminogen activator inhibitors
05/02/2003EP0728196B1 Mutants of a thermostable neutral protease from bacillus
05/02/2003EP0674710B1 Peptides with broad neoplastic specificity
05/02/2003EP0603216B1 Biocidal proteins
05/02/2003EP0599971B1 Yeast promoter and use thereof
05/02/2003EP0592521B1 Marrow-derived human mesenchymal stem cells and monoclonal antibodies specific for said cells
05/01/2003WO2003036255A2 Method for formulating a glucose oxidase enzyme with a desired property or properties and a glucose oxidase enzyme with the desired property
05/01/2003WO2003035887A1 Selection of cells expressing heteromeric polypeptides
05/01/2003WO2003035872A1 Human and mammalian stem cell-derived neuronal survival polypeptides
05/01/2003WO2003035848A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
05/01/2003WO2003035847A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003WO2003035840A2 69583 and 85924, novel human protein kinase family members and uses therefor
05/01/2003WO2003035835A2 Glycoprotein compositions
05/01/2003WO2003035826A2 Genetic screening methods
05/01/2003WO2003035697A1 Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same
05/01/2003WO2003035696A2 Humanized antibodies against icam-1, their production and uses
05/01/2003WO2003035694A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003WO2003035687A1 Nogo receptor homologues and their use
05/01/2003WO2003035686A2 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035682A2 Peptides and protins binding to glu-pro motidfs, therapeutical compositions containing them and their applications
05/01/2003WO2003035678A2 Sperm factor sequences
05/01/2003WO2003034984A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003WO2003034903A2 Psma antibodies and protein multimers
05/01/2003WO2002098897A3 Modified antibodies to prostate-specific membrane antigen and uses thereof
05/01/2003WO2002083712A3 Transporters and ion channels
05/01/2003WO2002081513A3 Disease-associated protein
05/01/2003WO2002076391A3 Microbial feeds for aquaculture and agriculture
05/01/2003WO2002074806A3 New interferon beta-like molecules
05/01/2003WO2002068668A3 Compositions and methods for production cell culture
05/01/2003WO2002063007A3 TIMM8b-RELATED PROTEIN
05/01/2003WO2002059322A9 Compositions and methods relating to the daptomycin biosynthetic gene cluster
05/01/2003WO2002038600A3 C. elegans genes involved in viability and/or reproduction and uses thereof
05/01/2003WO2002026250A3 Vaccines for proliferative ileitis
05/01/2003WO2002022851A3 Novel tumor-associated marker
05/01/2003WO2001079291A3 Secreted proteins
05/01/2003WO2001024681A3 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same
05/01/2003WO2000071564A3 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
05/01/2003US20030084484 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins
05/01/2003US20030084482 Particularly proteins that in their native state require the coordinate expression of a plurality of structural genes in order to become biologically active; therapy, medical diagnosis
05/01/2003US20030084474 Antibiotics-independent vector for constant high-expression and method for gene expression using the same
05/01/2003US20030084463 Method for the production of a protein
05/01/2003US20030083486 Physiologically active protein originating in mammals
05/01/2003US20030083481 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of prostate cancer
05/01/2003US20030083479 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083472 Cell surface molecule mediating cell adhesion and signal transmission
05/01/2003US20030083468 Polypeptide for use in the treatment of inflammation and liver disorders
05/01/2003US20030083467 Fusion proteins for use in the treatment of tumors and nervous sytem disorders
05/01/2003US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
05/01/2003US20030083462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083461 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083305 Modulating the immune response, reducing or inhibiting interferon expression; treating chronic inflammatory diseases and disorders, such as Crohn's disease, arthritis, Lyme disease, insulin-dependent diabetes, multiple sclerosis
05/01/2003US20030083257 Spliceable nucleotide sequence inserted into the wild-type factor viii cDNA at the original position of an intron of the genomic factor viii DNA; gene therapy; treatment of hemophilia
05/01/2003US20030083252 Neuronal uses of BMP-11
05/01/2003US20030083248 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083246 Methods for treating rheumatic diseases using a soluble CTLA4 molecule
05/01/2003US20030083240 Bactericides
05/01/2003US20030083229 Isolating T cells from mammal, incubating cells with protein expression product of activated oncogene or cancer-related gene associated with malignancy, detecting presence or absence of proliferation of T cells, determining malignancy
05/01/2003US20030082814 Secretion of T cell receptor fragments from recombinant escherichia coli cells
05/01/2003US20030082780 Nucleotide sequences coding polypeptide for use in the treatment of infections, pneumonia, toxic shock, brain and rheumatic diseases
05/01/2003US20030082766 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082764 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082763 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082762 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082761 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082760 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082759 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082758 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors
05/01/2003US20030082750 Preparation of beta-fructofuranosidase enzyme; prepare nutrient broth, inoculate with aspergillus, culture, cells, ferment beta-fructofuranosidase, separate and recover fructofuranosidase from culture
05/01/2003US20030082749 Fc fusion proteins of human erythropoietin with increased biological activities
05/01/2003US20030082748 Nucleotide sequences coding polypeptides for use in the treatment of leukemia, tumors, psoriasis, chronic infections, autoimmune and fibrotic disorders; wound healing agents
1 ... 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 ... 1125